Form 4 for SRPT Sarepta Therapeutics, Inc.
Accepted 2024-03-06 00:00:00 ET · period of report 2024-03-04 · accession 0000950170-24-027496 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-06 | 2024-03-04 | SRPT | Rodino-Klapac Louise | CSO, Head of R, D | F - Tax | $125.32 | -1,728 | 69.5K | -2% | -$216.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-04 | F | D | 1,728 | $125.32 | 69,494 | D | — | — | (F1) Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021. |